Q32 Bio Investor Relations Material
Latest events
Q1 2025
8 May, 2025
Q4 2024
11 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Q32 Bio Inc
Access all reports
Q32 Bio Inc. is a clinical-stage biotechnology company focused on developing biologic therapeutics designed to restore immune balance in patients with autoimmune and inflammatory diseases. The company's product pipeline includes innovative treatments targeting both the innate and adaptive immune systems. The company is based in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Q32 Bio Inc
Q3 2024
Q32 Bio Inc
Corporate Presentation
Q32 Bio Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
QTTB
Country
🇺🇸 United States